Navigation Links
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
Date:2/26/2013

HONG KONG, Feb. 26, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the third quarter and first nine months of fiscal year 2013, which ended December 31, 2012.

Third Quarter of Fiscal 2013 Highlights

  • Revenues for the third quarter of fiscal 2013 increased by 57.5% to RMB149.3 million ($24.0 million) from RMB94.8 million in the prior year period.
  • New subscriber sign-ups increased 65.0% year-over-year to 21,218.
  • Accumulated subscriber base amounted to 295,923.
  • Gross profit increased by 65.6% to RMB121.1 million ($19.4 million) from RMB73.1 million in the prior year period.
  • Gross margin was 81.1%, an increase from 77.1% in the prior year period.
  • Operating income increased by 112.9% to RMB67.1 million ($10.8 million) from RMB31.5 million in the prior year period.
  • Interest expense amounted to RMB23.8 million ($3.8 million), compared to RMB0.7 million in the prior year period.
  • Income before income tax for the third quarter grew by a lesser extent of 29.7% because of higher interest expense and lack of exchange gain.
  • Net income attributable to the Company was RMB33.6 million ($5.4 million), a decrease of 14.8% compared to the same period last year also due to higher interest expense and lack of exchange gain and a one-time tax benefit recorded in the third quarter of fiscal 2012.  
  • Operating cash inflow for the quarter amounted to RMB144.1 million ($23.1 million).
  • First Nine Months of Fiscal 2013 Highlights

  • Revenues for the first nine months of fiscal 2013 increased by 40.0% to RMB393.1 million ($63.1 million) f
    '/>"/>

  • SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
    2. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
    3. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
    4. Lucintel’s Analysis of Growth Opportunities in China’s Composites Industry: Expect Market to Surpass $11 Billion in 2017
    5. China Cord Blood Corporation to Further Consolidate its Corporate Structure
    6. Biomaterials China News 1210 - Annual Subscription
    7. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
    8. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
    10. China Biologic Products to Report Third Quarter 2012 Financial Results
    11. Life Technologies New State-of-the-Art Manufacturing Facility in China Provides Forensics Labs Rapid Access to World-Leading DNA Testing Solutions
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/18/2014)... Athena Signature Series: Turning Cancer ‘Off’ – ... a professor in the Regulatory Biology Laboratory at the Salk ... points to an “off switch” for drug resistance in cancer. ... local research is making a global impact in the fight ... join host Cheryl K. Goodman, CEO of Social Global Mobile ...
    (Date:11/18/2014)... Brothers Josh and Bryce Benbasat (ages ... PAWSitively Curing Cancer, Inc . in recognition of National ... organization is dedicated to raising funds for pet cancer ... University of Florida College of Veterinary Medicine . ... as the recipient of this vital funding. It will ...
    (Date:11/18/2014)... 18, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... with the acquisition of Durata Therapeutics, Inc. by Actavis, ... the termination of PDL,s credit agreement with Durata, which ... $40 million, accrued interest, and prepayment and change of ... structured financing transaction with Durata in which PDL agreed ...
    (Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., a ... treatment of chronic hepatitis B virus (HBV) infection, today ... appointed to its Scientific Advisory Board (SAB).  ... SAB," said Christian S. Schade , Chief Executive ... development experience which will be invaluable to Novira as ...
    Breaking Biology Technology:PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3
    ... Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced ... upcoming Morgan Stanley Global Healthcare Unplugged,Conference to be ... Sept. 9, 2008. Dr.,Peter Thompson, president, chief executive ... appointed senior vice president and chief medical,officer, are ...
    ... HAYWARD, Calif., Aug. 27 Thermage, Inc.,(Nasdaq: ... in the aesthetic,industry, announced today that it will ... at the Four Seasons Hotel in Boston. The,Company,s ... at,4:25 p.m. Eastern Time. Stephen Fanning, Chairman, President ...
    ... year consolidated financial statements:, (EUR millions) ... ... ... 74.8 100.0 87.0 ...
    Cached Biology Technology:Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York 2Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 2Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit 3
    (Date:11/18/2014)... Nov. 17, 2014 The Parenteral Drug Association (PDA) ... agencies will speak and at least seven more will participate ... the Omni Shoreham Hotel in Washington D.C. ... to have significant support from the regulatory agencies in ... in our effort to help advance the use ...
    (Date:11/11/2014)... Inc., a Chicago -based digital forensics ... of Yaniv Schiff from Senior Computer Forensics ... role as Director, he will lead company efforts to ... provide leadership within the company,s digital forensics practice area.  ... Schiff joined Forensicon in 2006 and has ...
    (Date:11/7/2014)... , November 6, 2014 Leading ... for better mobile security revolutionizing online transactions.  Companies in focus ... Holdings Ltd. (NYSE: BABA ), Google Inc. (NASDAQ: ... ), eBay Inc. (NASDAQ: EBAY ) and MasterCard ... NXTD and NXTDW), a biometric authentication company focused on ...
    Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6
    ... and motor fibers interact to form nerves in the ... Brsamle of the Institute of Developmental Genetics of Helmholtz ... at the molecular level: The cell surface receptor neuropilin-1 ... and controls their interaction in order to correctly regulate ...
    ... (March 7, 2011) -- All our daily activities, from driving ... carried along the body,s vast network of neurons. Propagation of ... within nerve cells -- receptors, ion channels, and transmitters -- ... study of these molecules in real time has not been ...
    ... knee arthroplasty surgery could pay dividends - for both ... of surgery can improve pain, range of joint motion ... according to new research in the journal Clinical ... trend towards discharging patients from hospital more rapidly after ...
    Cached Biology News:Rehabilitation within a day of knee replacement pays off 2
    Kit includes your choice of reagents for labeling 3 x 10 9 cells and EasySep magnet....
    Plasmid expressing PLAP reporter gene....
    Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
    ...
    Biology Products: